Amarin Corp Plc (AMRN)

[rosemountbomber]

Zip, those PAs are the smoking gun. Your post also made me think about a different subject. You said:

“…to save money for themselves by dispensing the generic version, which they pay less for. “

So does that mean that in those exclusivity arrangements that KM has negotiated with some insurers, that V is costing them less than the GV?

I would have to assume so or else what is the benefit to the insurance co? And, if that is the case then it seems that Amarin could if they wanted to undercut the Generics for the entire US market. Now the margin must be rather small and I assume that is why it sounded like KM was only going to arrange the exclusivity deals for approx 50% of the US market. I assume the overheads ( even after all the cuts) are still a bit too high.

Am I understanding the dynamics here correctly?